InsidersTradesSigma
Discover the detailed record of transactions filed by Sebaaly Camille, 首席财务官. Officer active across 1 company, notably Sunshine Biopharma, Inc. In total, 1 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €28k. History available since 3 June 2022. The latest transaction was disclosed on 3 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Camille Sebaaly is the Chief Financial Officer and Secretary of Sunshine Biopharma, Inc., a biopharmaceutical company. In her role, she oversees financial operations and governance matters. Camille brings expertise in finance and business management, contributing to Sunshine's growth strategy.